.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India’s flagship health insurance programme has significantly improved access to oncology treatments. Ayushman Bharat cancer care serves as a critical lifeline for rural and low-income populations facing high medical costs. However, while the scheme has covered millions of treatments, significant financial gaps persist. Experts emphasize that the current allocation often falls short of the comprehensive care required for long-term survival.
The FinCan study highlights that the program requires an annual budget of ₹33,000 crore to provide full standard-of-care services. Currently, the allocation stands at roughly ₹7,700 crore per year. Consequently, this disparity limits the ability of many families to access advanced therapies. Therefore, researchers recommend shifting from a ₹5 lakh annual cap to a ₹25 lakh revolving ceiling over five years. This change would allow patients to utilize more funds during high-cost treatment phases.
Early detection remains the most effective way to reduce the economic and clinical burden of oncology. Furthermore, integrating diagnostic coverage into the scheme could save approximately ₹1,500 crore annually. By aligning screening protocols with global benchmarks, India could potentially save over 30,000 additional lives each year. Moreover, the 2025-26 Union Budget has already earmarked funds for 200 new day-care cancer centers to expand rural access. These steps indicate a positive move toward universal health coverage.
Q1: How does the FinCan study suggest improving cancer funding?
The study recommends a ₹25 lakh revolving ceiling for families and a ₹10 lakh top-up for high-stage cancer patients.
Q2: Why is early diagnosis emphasized in the new study?
Early diagnosis and treatment initiation can save ₹1,500 crore annually and prevent late-stage suffering while improving survival rates.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FinCan study advocates for restructured AB-PMJAY funding and early diagnosis to enhance cancer survival rates and reduce financial burdens in India....
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
